Advertisement

Acta Diabetologica

, Volume 56, Issue 4, pp 481–483 | Cite as

Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetes

  • Milo GattiEmail author
Case Report
  • 278 Downloads
Part of the following topical collections:
  1. Pregnancy and diabetes

Introduction

Pregnant patients affected by type 1 diabetes (T1DM) are at increased risk for maternal and fetal risk, including congenital malformations, preeclampsia, macrosomia, spontaneous abortion, and perinatal mortality [1]. Tight glycemic control is required to reduce the occurrence of diabetes related pregnancy complications. The more stringent glucose targets and the wide variability in insulin requirement during pregnancy may predispose to hypoglycemic events, and severe hypoglycemia occurs in up to 50% of pregnancies women with T1DM [1, 2]. The National Institute for Health and Care Excellence recommends that blood glucose levels are tested up to eight times daily to achieve glycemic targets [2]. However, many patients experience barriers to frequent testing, including pain and discomfort associated with the multiple finger-stick blood samples. Continuous glucose monitoring (CGM) may improve quality of life in T1DM patients, providing a good accuracy without the pain and the...

Keywords

Type 1 diabetes Flash glucose monitoring Pregnancy Feasibility 

Notes

Acknowledgements

A special thanks to Dr. Sergio Arlati for his support in statistical analyses.

Funding

None to declare.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest. Case report was performed as part of routine work and fully independently of the FreeStyle Libre manufacturer.

Ethical standard statement

The study was performed in accordance with the ethical standards (institutional and national) laid down in Declaration of Helsinki.

Informed consent

The patient gave her informed consent for being included in the study.

Supplementary material

592_2018_1252_MOESM1_ESM.xls (10 kb)
Supplementary material 1 (XLS 10 KB)

References

  1. 1.
    American Diabetes Association (2018) Management of diabetes in pregnancy: standards of medical care in diabetes—2018. Diabetes Care 41(S1):S137–S143CrossRefGoogle Scholar
  2. 2.
    National Institute for Health and Care Excellence (2015) Diabetes in pregnancy: management from preconception to the postnatal period guideline. https://www.nice.org.uk/guidance/ng3. Accessed 17 May 2008
  3. 3.
    Law GR, Ellison GT, Secher A et al (2015) Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care 38:1319–1324CrossRefPubMedGoogle Scholar
  4. 4.
    Olafsdottir AF, Attvall S, Sandgren U et al (2017) A clinical trial of the accuracy and treatment experience of the Flash Glucose Monitor FreeStyle Libre in adults with type 1 diabetes. Diabetes Technol Ther 19(3):164–172CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Scott EM, Bilous RW, Kautzky-Willer A, Accuracy (2018) User acceptability, and safety evaluation for the FreeStyle Libre Flash Glucose Monitoring System when used by pregnant women with diabetes. Diabetes Technol Ther 20(3):180–188CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Oncology and Onco-Hematology, Postgraduate School of Clinical Pharmacology and ToxicologyUniversity of MilanMilanItaly

Personalised recommendations